Natus Medical Incorporated
Medical Devices & Tech
1501 Industrial Road
San Carlos, CA 94070 USA
phone: (650) 802-0400
fax: (650) 802-0401
Symbol BABY
Exchange Nasdaq
Founded 1987
Employees 220
www.natus.com
Research Sector Medical Devices & Tech
Summary Description
Products for newborn health.
Management
James B. Hawkins, President & CEO; Steven J. Murphy, Vice President Finance & CFO; William L. Mince, Vice President, Operations; Kenneth M. Traverso, Vice President, Marketing & Sales; D. Christopher Chung, M.D., Vice President, Medical Affairs, R&D, and Engineering
Ownership
Financials Mkt Cap :424


* numbers in thousands

Recent Results
Revenues of $21.8 million for the quarter ended September 30, 2006, an increase of 107% compared to $10.6 million reported in the same period in 2005. The increase was primarily attributable to the acquisition of Bio-logic Systems Corp. in January of 2006.
 
Keywords
jaundice, newborn, premie, hearing screening, children, neo-natal, neonatal, heat shields, oxygen delivery, oxygen therapy, screening, noise, hearing, noise attenuators

Comment | Printable Version | Nov. 01, 2008
If you work for Natus Medical Incorporated and want to update this profile, click here

Description
Natus Medical develops, manufactures and markets products for the detection, treatment, monitoring and tracking of common medical disorders in newborns. The company operates in two segments: medical devices and related supplies segment, and software systems segment.
Products / Services
The company's principal product lines consist of its ALGO screening products for hearing screening, its Echo-Screen otoacoustic emissions (OAE) device for hearing screening in newborns and hearing monitoring in young children and adults, its neoBLUE LED line of phototherapy devices (neoBLUE phototherapy devices) for the treatment of newborn jaundice, its Neometrics newborn screening data management system, MiniMuffs neonatal noise attenuators (MiniMuffs) products for the attenuation of noise for newborns, and the Nascor product line.
Technology / Differentiation
The ALGO screening product family utilizes automated auditory brainstem response (AABR) technology to provide non-invasive and automated hearing screening for newborns. The ALGO screener uses a number of sensors placed on the newborn's head to measure the response of the brain and auditory nerves to sounds delivered through specially designed earphones.
Market / Customers

Competitors / Substitutes / Alternatives

Strategy

Funding
Status


2008-11-23-520